This news or article is intended for readers with certain scientific or professional knowledge in the field. Enzalutamide is one of the main treatments for patients with metastatic, castration-resistant prostate cancer — the lethal form of the disease. However, treatment options are limited for those who develop resistance to enzalutamide. Now, a multi-institution team has...
Tag: <span>health science</span>
Synapse-saving proteins discovered, opening possibilities in Alzheimer’s, schizophrenia
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO GEK-MING SIA, PHD, AND COLLEAGUES IN THE LONG SCHOOL OF MEDICINE AT UT HEALTH SAN ANTONIO DISCOVERED A NEW CLASS OF PROTEINS THAT SPARE SYNAPSES FROM ELIMINATION. INCREASING THE NUMBERS… view more CREDIT: UT HEALTH SAN ANTONIO Researchers at The University of Texas Health Science Center...
A new way to control Epstein-Barr virus
by Chris Palmer, University of Utah Health Sciences This electron microscopic image of two Epstein Barr Virus virions (viral particles) shows round capsids—protein-encased genetic material—loosely surrounded by the membrane envelope. Credit: DOI: 10.1371/journal.pbio.0030430.g001 A team of researchers at University of Utah Health have shown the Epstein-Barr virus—which causes mononucleosis and is linked to development of...
Searching for the origins of the depressive symptoms in Huntington’s disease
Cdk5 Kinase: An essential protein UNIVERSITY OF BARCELONA About 40% of the affected patients with Huntington’s disease -a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of the typical motor symptoms of the disease. An altered function of Cdk5 kinase -an essential enzyme in several cell signalling pathways- could explain the physiopathology of the depressive-like behaviour in Huntington’s disease, according to...